Form 4: BioDeisx Executive Sells Shares to Cover Taxes After RSU Vesting

BioDeisx Chief Development Officer, Gary Pestano, sold shares to cover taxes after restricted stock units vested.

Summary

• Gary Pestano, Chief Development Officer at BioDeisx, engaged in transactions involving the company's common stock.
• On November 8, 2024, 1,378 restricted stock units (RSUs) vested, each representing one share of common stock.
• Following the vesting, shares were sold to cover taxes.
• On November 11, 2024, 220 shares were sold at a weighted average price of $1.3909 per share.
• On November 12, 2024, 207 shares were sold at a weighted average price of $1.4008 per share.
• After these transactions, Pestano directly owns 127,027 shares of BioDeisx common stock.

Sentiment

Score: 5

Explanation: This is a neutral event, reflecting routine executive compensation and tax obligations. It does not indicate any positive or negative sentiment about the company's performance.

Industry Context

This is a routine transaction for executives who receive stock-based compensation. It is common for shares to be sold to cover tax obligations upon vesting.

Comparison to Industry Standards

• The sale of shares to cover taxes upon vesting of RSUs is a standard practice across many publicly traded companies.
• Similar transactions are regularly reported by executives at comparable biotech and healthcare companies.

Stakeholder Impact

• The transactions have a minimal impact on shareholders as they are routine and related to executive compensation.

Key Dates

Keywords

BioDeisx, BDSX, Gary Pestano, restricted stock units, RSU, insider trading, stock sale, tax obligations